Literature DB >> 4005105

The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites.

P C Ho, E J Triggs, D W Bourne, V J Heazlewood.   

Abstract

The disposition of a low dose (600 mg) of acetylsalicylic acid (ASA) and its metabolites (salicylate, salicyluric acid and salicyl glucuronides) was studied in 25 male and female patients of different ages. Plasma levels of ASA and salicylate were found to be significantly higher in the females (young and elderly), whereas plasma levels of salicyluric acid were found to be significantly higher in the elderly (male and female) groups. The higher plasma levels of ASA and salicylate in the females appear to be due to an intrinsically lower metabolic activity in that sex, while the lower clearance of salicyluric acid leads to the accumulation of that compound in the aged. No age and sex effects were found to influence the volumes of distribution of ASA, salicylate and salicyluric acid.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4005105      PMCID: PMC1463851          DOI: 10.1111/j.1365-2125.1985.tb02695.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  41 in total

1.  Detoxication mechanisms in man.

Authors:  R T WILLIAMS
Journal:  Clin Pharmacol Ther       Date:  1963 Mar-Apr       Impact factor: 6.875

2.  Evidence for a sex-linked difference in aspirin metabolism.

Authors:  R Menguy; L Desbaillets; Y F Masters; S Okabe
Journal:  Nature       Date:  1972-09-08       Impact factor: 49.962

3.  Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man.

Authors:  G Levy; T Tsuchiya; L P Amsel
Journal:  Clin Pharmacol Ther       Date:  1972 Mar-Apr       Impact factor: 6.875

4.  The influence of age on the activity of acetylsalicylic acid-esterase and protein-salicylate binding.

Authors:  A Windorfer; W Kuenzer; R Urbanek
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

5.  Absorption kinetics of aspirin in man following oral administration of an aqueous solution.

Authors:  M Rowland; S Riegelman; P A Harris; S D Sholkoff
Journal:  J Pharm Sci       Date:  1972-03       Impact factor: 3.534

6.  Intolerance to aspirin. Clinical studies and consideration of its pathogenesis.

Authors:  M Samter; R F Beers
Journal:  Ann Intern Med       Date:  1968-05       Impact factor: 25.391

7.  Capacity-limited salicylurate formation during prolonged administration of aspirin to healthy human subjects.

Authors:  G Levy; A W Vogel; L P Amsel
Journal:  J Pharm Sci       Date:  1969-04       Impact factor: 3.534

8.  Influence of the route of administration on the area under the plasma concentration-time curve.

Authors:  P A Harris; S Riegelman
Journal:  J Pharm Sci       Date:  1969-01       Impact factor: 3.534

9.  Kinetics of salicyluric acid elimination in man.

Authors:  G Levy; L P Amsel; H C Elliott
Journal:  J Pharm Sci       Date:  1969-07       Impact factor: 3.534

10.  Effect of corticosteroids on blood salicylate concentration.

Authors:  J R Klinenberg; F Miller
Journal:  JAMA       Date:  1965-11-08       Impact factor: 56.272

View more
  20 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.

Authors:  Arduino A Mangoni
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

3.  Aspirin as a COX inhibitor and anti-inflammatory drug in human skeletal muscle.

Authors:  Stephen M Ratchford; Kaleen M Lavin; Ryan K Perkins; Bozena Jemiolo; Scott W Trappe; Todd A Trappe
Journal:  J Appl Physiol (1985)       Date:  2017-07-13

Review 4.  Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.

Authors:  J O Miners
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

5.  Route of administration and sex differences in the pharmacokinetics of aspirin, administered as its lysine salt.

Authors:  L Aarons; K Hopkins; M Rowland; S Brossel; J F Thiercelin
Journal:  Pharm Res       Date:  1989-08       Impact factor: 4.200

6.  Pharmacokinetics of low-dose oral modified release, soluble and intravenous aspirin in man, and effects on platelet function.

Authors:  F Bochner; D B Williams; P M Morris; D M Siebert; J V Lloyd
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  Sex differences in proximal and distal nephron function contribute to the mechanism of idiopathic hypercalcuria in calcium stone formers.

Authors:  Benjamin Ko; Kristin Bergsland; Daniel L Gillen; Andrew P Evan; Daniel L Clark; Jaime Baylock; Fredric L Coe; Elaine M Worcester
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-05-06       Impact factor: 3.619

Review 8.  Gender differences in pharmacokinetics.

Authors:  C H Gleiter; U Gundert-Remy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

Review 9.  Gender effects in pharmacokinetics and pharmacodynamics.

Authors:  R Z Harris; L Z Benet; J B Schwartz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

10.  Bioinequivalence of four 100 mg oral aspirin formulations in healthy volunteers.

Authors:  F Bochner; A A Somogyi; K M Wilson
Journal:  Clin Pharmacokinet       Date:  1991-11       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.